Literature DB >> 25764257

Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.

Fereshteh Ashtari, Seyed Amir Bahreini, Hamid Zahednasab.   

Abstract

Multiple sclerosis (MS) is a common demyelinating disease of the central nervous system in which an abnormal immune system response results in damage to the myelin sheaths surrounding nerves. The etiology of MS remains elusive, although it has been suggested to be influenced by both genetic and environmental factors. Here, we report two exceptional cases of patients affected by both MS and Thomsen's myotonia. Electromyography and MRI scans confirmed the presence of both diseases in the referred cases. Although the mechanisms underlying the co-occurrence of MS and Thomsen's disease are unclear, we have endeavored to offer plausible explanations for it.

Entities:  

Mesh:

Year:  2014        PMID: 25764257      PMCID: PMC4370440     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  10 in total

1.  Clinical, electrophysiological and genetic features of a large Australian family with paramyotonia congenita.

Authors:  Sharavanan Parasivam; Malgorzata Krupa; Mark Slee; Dominic E Thyagarajan; Thyagarajan E Dominic
Journal:  Med J Aust       Date:  2009-03-16       Impact factor: 7.738

Review 2.  Membrane changes in cells from myotonia patients.

Authors:  R Rüdel; F Lehmann-Horn
Journal:  Physiol Rev       Date:  1985-04       Impact factor: 37.312

3.  Identification of two mutations and a polymorphism in the chloride channel CLCN-1 in patients with Becker's generalized myotonia.

Authors:  J Esteban; A M Neumeyer; D McKenna-Yasek; R H Brown
Journal:  Neurogenetics       Date:  1998-03       Impact factor: 2.660

4.  A population-based study of multiple sclerosis in twins.

Authors:  G C Ebers; D E Bulman; A D Sadovnick; D W Paty; S Warren; W Hader; T J Murray; T P Seland; P Duquette; T Grey
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

5.  Myotonic-like syndrome in multiple sclerosis.

Authors:  M I Weintraub; M S Megahed; B H Smith
Journal:  N Y State J Med       Date:  1970-03-01

6.  Identification of five new mutations and three novel polymorphisms in the muscle chloride channel gene (CLCN1) in 20 Italian patients with dominant and recessive myotonia congenita. Mutations in brief no. 118. Online.

Authors:  F Sangiuolo; A Botta; A Mesoraca; S Servidei; L Merlini; G Fratta; G Novelli; B Dallapiccola
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

7.  Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders.

Authors:  E Farbu; E Søfteland; L A Bindoff
Journal:  Acta Anaesthesiol Scand       Date:  2003-05       Impact factor: 2.105

8.  Stiffness as a presenting symptom of an odd clinical condition caused by multiple sclerosis and myotonia congenita.

Authors:  Simona Portaro; Olimpia Musumeci; Vincenzo Rizzo; Carmelo Rodolico; Mary G Sweeney; Maria Buccafusca; Michael G Hanna; Antonio Toscano
Journal:  Neuromuscul Disord       Date:  2012-08-24       Impact factor: 4.296

9.  Multiple sclerosis in Isfahan, Iran.

Authors:  Mohammad Saadatnia; Masoud Etemadifar; Amir Hadi Maghzi
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

10.  Myotonic dystrophy and multiple sclerosis.

Authors:  C F Terrence
Journal:  J Neurol       Date:  1976-10-04       Impact factor: 4.849

  10 in total
  2 in total

1.  Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.

Authors:  Eloy Roura; Torben Schneider; Marc Modat; Pankaj Daga; Nils Muhlert; Declan Chard; Sebastien Ourselin; Xavier Lladó; Claudia Gandini Wheeler-Kingshott
Journal:  Funct Neurol       Date:  2015 Oct-Dec

2.  A case report of recessive myotonia congenita and early onset cognitive impairment: Is it a causal or casual link?

Authors:  Simona Portaro; Alberto Cacciola; Antonino Naro; Demetrio Milardi; Rosa Morabito; Francesco Corallo; Silvia Marino; Alessia Bramanti; Emanuela Mazzon; Rocco Salvatore Calabrò
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.